Showing metabocard for Monamycin (MMDBc0060778)
Microbial
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-02 23:01:13 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:20 UTC | ||||||||||||
| Metabolite ID | MMDBc0060778 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | Monamycin | ||||||||||||
| Description | Monamycin is a cyclodepsipeptide antibiotic belonging to the class of natural products. Its chemical structure features a cyclic arrangement of amino acids and ester bonds, which contribute to its unique properties and biological activity. Monamycin is involved in various biochemical pathways, particularly in its interaction with cations, forming complexes that influence its mode of action (PMID:5443702 ). The antibiotic's efficacy has been shown to be inversely proportional to its unsolvated molecular weight, suggesting that structural characteristics play a significant role in its antimicrobial activity (PMID:4790597 ). Additionally, the biosynthesis of brominated analogues of monamycin has been observed when Streptomyces jamaicensis is grown in a low-chloride medium supplemented with NaBr, indicating the potential for chemical modification and exploration of its derivatives (PMID:4790597 ). Overall, monamycin's complex structure and its interactions within biological systems highlight its significance in the study of antibiotic mechanisms. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C32H53N7O7 | ||||||||||||
| Average Mass | 647.818 | ||||||||||||
| Monoisotopic Mass | 647.400647075 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | WTLGBIQVBFJEGX-UHFFFAOYNA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | WTLGBIQVBFJEGX-UHFFFAOYSA-N | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References |
| ||||||||||||
